Rick Doblin
Rick Doblin
Rick Doblin, PhD, is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four-year follow-up study to Timothy Leary’s Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. He founded MAPS in 1986, and currently resides in Boston with his wife.
MORE PROGRAMS
MDMA-assisted Therapy for PTSD: Its History, Research Data, Therapeutic Approach and Future – 2 CE’S
with Rick Doblin, PhD, Michael Mithoefer, MD, and Annie Mithoefer, BSA
ABOUT THIS PROGRAM
An Evening Event
Monday, March 15, 2021, 7:00 – 9:00 pm EST
This program can be taken individually or as part of the 6-part series, The Psychedelic Renaissance: Past, Present & Future. Recordings of past events in this series are available on demand with registration for the full program. To register for the full series, click here.
Please note CE’s are available only for classes participants attend live, not recorded sessions.
For almost two decades, MAPS (The Multidisciplinary Association for Psychedelic Studies) has been conducting FDA-regulated drug development research into MDMA-assisted therapy for PTSD in the United States, Switzerland, Israel and Canada. We have completed Phase 1 and Phase 2 studies and the first of two Phase 3 studies, with very promising results.
We’re also starting research in five countries in Europe and England for approval by the European Medicines Agency in England, Netherlands, Portugal, Germany, the Czech Republic and Norway. The FDA has awarded Breakthrough Therapy designation to MDMA-assisted Therapy for PTSD.
This evening will address the history of MDMA, our safety and efficacy data, information about mechanisms of action and our therapeutic approach and possible post-approval regulations. We currently anticipate FDA approval around the end of 2022 or early 2023. Approval in Europe would be a year or so later, depending on the availability of funding.
DISCLAIMER: The Open Center, its staff, and presenters do not endorse or encourage the use of psychedelics or any other substances. Substances discussed may be illegal in your country except under very specific circumstances, such as sanctioned medical studies. Any information presented in programs is for curiosity, education and research purposes only.
SCHEDULE & LEARNING OBJECTIVES
Click HEREÂ
Note: This program will be offered online. Sessions of all our online programs will be recorded and shared with registrants after each is completed for 90 days.
CE’S AVAILABLE
MDMA-Assisted Therapy for PTSD
Seminar Code: NYOC-PR-004
Presenter(s): Rick Doblin, Ph.D., Michael Mithoefer, MD and Annie Mithoefer, BSN
Date(s): 3/15/21 | 7:00 – 9:00 pm EST
Metro: Live Interactive Online Webinar
Pricing Information:
Continuing Education Credits (2) $15.00
Please note this fee is for the CE certificate only in addition to the program fee – $40.00
For eligible professions and to purchase the CEs click HERE.
CE certificates will be eligible for download following the course completion at www.ceuregistration.com
The course content is suitable for all levels: Introductory, Beginning, Advanced.
There is no conflict of interest or commercial support for this program.
Refund & Cancellation Policy – click HERE. For questions or concerns, contact registration@opencenter.org.
THIS PROGRAM IS OPEN TO THE PUBLIC. CEs ARE AVAILABLE TO THE FOLLOWING ELIGIBLE PROFESSIONS:
- Psychoanalysts
- Social Workers
- Counselors
- Creative Arts Therapists
- Educators
- Nurses
WHAT YOU’LL NEED FOR THIS COURSE
- Prerequisites: N/A
- Supplies list for the class: N/A
- Zoom Software Requirements: This is an online course that requires Zoom webinar software. Zoom is easy to use. Click HERE to make sure your computer is set-up correctly.
MDMA-assisted Therapy for PTSD: Its History, Research Data, Therapeutic Approach and Future – 2 CE’S
21SCMH23E- 1 Session(s)
- Mar 15 2021 7:00 PM ET
Members
$38Non-Members
$45Rick Doblin, PhD, is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS).
Annie Mithoefer, B.S.N., is a Registered Nurse who is now focused primarily on training and supervising therapists conducting MAPS-sponsored clinical trials.
Michael Mithoefer, MD, is Senior Medical Director for Medical Affairs, Training and Supervision at MAPS Public Benefit Corporation.
The Psychedelic Renaissance: Past, Present and Future – 12 CE’s
“An all-star line-up: The Psychedelic Renaissance: Past, Present and Future – The Open Center” – Michael Pollan, Author of How to Change Your Mind
ABOUT THIS PROGRAM
A Weekly Class
(6 Sessions) Mondays, February 22 – March 29, 2021, 7:00 – 9:00 pm EST
Recordings of past events in this series are available on demand with registration for the full program. Please note CE’s are available only for classes participants attend live, not recorded sessions.
This unique series of evening presentations addresses the history of psychedelics from classical antiquity and among Amazonian shamans through current research investigating the therapeutic value of psilocybin, MDMA and other compounds for clinical applications including PTSD, addiction, existential distress in palliative care and clinical depression. Implications for the utilization of these novel therapies for the future of healthcare will be addressed.
We are living in the midst of a renaissance of research into psychedelic (or entheogenic) substances. Decades of promising research into their extraordinary benefits for numerous medical conditions were brought to a stop in the 1970s, amid the cultural turbulence of the era. In recent years, we have witnessed a reemergence of scientific and clinical research with promising findings at premier institutions including Johns Hopkins, NYU and UCLA.
At a time when we may be seeing the limitations of modern psychiatry’s medicine cabinet, these novel compounds and ancient medicines are in the process of returning to a status of respect and recognition within medical research. Many of those who take them under carefully controlled clinical research conditions report having extremely meaningful and therapeutic experiences, leading to promising implications for various forms of clinical suffering.
Join us as we provide a broad context and invigorating conversation for understanding these extraordinary substances, from their possible role in the mystery centers of Ancient Greece, their integral place among the indigenous cultures of the Western Hemisphere, and to their current place in modern medical research.
DISCLAIMER: The Open Center, its staff and presenters do not endorse or encourage the use of psychedelics or any other substances. Substances discussed may be illegal in your country except under very specific circumstances, such as sanctioned medical studies. Any information presented in programs is for curiosity, education and research purposes only.
Moderator | Speaker
Anthony P. Bossis, Phd
CLASS SCHEDULE
Week 1: The Immortality Key: The Secret History of the Religion with No Name – 2 CE’s
Week 2: The Utility of Psychedelics in the Treatment of End-of-Life Emotional Suffering: A Promising Therapeutic Paradigm – 2 CE’s
Week 3: An Overview of Psilocybin Research at Johns Hopkins: Its History, Current state and Future Directions – 2 CE’s
Week 4: MDMA-assisted Therapy for PTSD: Its History, Research Data, Therapeutic Approach and Future – 2 CE’s
Week 5: Ayahuasca, Magic Mushrooms, Richard Schultes and Biodiversity Conservation – 2 CE’s
Week 6: Psilocybin Mushrooms and The Ecology of Consciousness – 2 CE’s
SCHEDULE & LEARNING OBJECTIVES
Click HEREÂ
Note: This program will be offered online. Sessions of all our online programs will be recorded and shared with registrants after each is completed for 90 days.
In case you missed it, you can view the recent Open Center LIVE, The Contemporary Psychedelic Resurgence with Anthony Bossis HERE.
CE’S AVAILABLE
The Psychedelic Renaissance: Past, Present and Future
Seminar Code: NYOC-PR-ALL
Presenter(s): Mark Plotkin, Ph.D., Anthony P. Bossis, Ph.D., Rick Doblin, Ph.D., Michael Mithoefer, MD, Annie Mithoefer, BSN, William Richards Ph.D. and Albert Garcia-Romeu, Ph.D.
Date(s): 2/22/21, 3/1/21, 3/8/21, 3/15/21, 3/22/21 and 3/29/21
Metro: Live Interactive Online Webinar
Pricing Information:
Continuing Education Credits (12) $40.00
Please note this fee is for the CE certificate only in addition to the program fee – $40.00
For eligible professions and to purchase the CEs click HERE.
CE certificates will be eligible for download following the course completion at www.ceuregistration.com
The course content is suitable for all levels: Introductory, Beginning, Advanced.
There is no conflict of interest or commercial support for this program.
Refund & Cancellation Policy – click HERE. For questions or concerns, contact registration@opencenter.org.
THIS PROGRAM IS OPEN TO THE PUBLIC. CEs ARE AVAILABLE TO THE FOLLOWING ELIGIBLE PROFESSIONS:
- Psychoanalysts
- Social Workers
- Counselors
- Creative Arts Therapists
- Educators
- Nurses
SPONSORSHIP
Sponsorship opportunities are available. Contact marketing@opencenter.org.
WHAT YOU’LL NEED FOR THIS COURSE
- Prerequisites: N/A
- Supplies list for the class: N/A
- Zoom Software Requirements: This is an online course that requires Zoom webinar software. Zoom is easy to use. Click HERE to make sure your computer is set-up correctly.
The Psychedelic Renaissance: Past, Present and Future – 12 CE’s
21SCMH20X- 6 Session(s)
- Feb 22 2021 7:00 PM ET
Members
$195Non-Members
$230
